PsychoactiveMap

Tel-Aviv Sourasky Medical Center psychedelic research trials

Data as of 11 October 2026. Source: ClinicalTrials.gov records held by PsychoactiveMap, refreshed from a reviewed snapshot.

Tel-Aviv Sourasky Medical Center is listed with 3 registered studies counted here, in Tel Aviv, Israel. By compound: 1 psilocybin and 2 ketamine. By registry status: 1 recruiting and 2 status not reported. By phase: 1 early phase 1, 1 phase 1 and 1 phase 3. Reported start years run from 2014 (earliest) to 2025 (latest).

Institution name, city and country are copied from the research site linked to each registry record. A study counts once per institution, and a study tagged with more than one compound is counted under each compound.

Educational information, not medical advice. A registry listing is not evidence of safety, benefit or results, and it is not a recommendation. PsychoactiveMap does not recruit, screen or refer participants. Status and other details are copied from the registry and can be out of date, so check the registry record and speak to a qualified health professional before any decision. Read the full disclaimer.

At a glance

By compound

Compound hubStudies
Psilocybin1
Ketamine2

By registry status

StatusStudiesShare
Recruiting133%
Status not reported267%

By phase

PhaseStudiesShare
Early Phase 1133%
Phase 1133%
Phase 3133%

Registered studies

All counted studies, newest start first. The order is not a ranking and says nothing about quality. Titles are quoted from the registry. Each ID links to its own ClinicalTrials.gov record, which has the eligibility criteria and contacts.

Title as registeredRegistry IDStatusPhaseStartCompound
Trauma-informed Psilocybin Assisted Psychotherapy (TiPAP) for PTSDNCT07737054RecruitingEarly Phase 12025-07-22Psilocybin
The Effect of Intravenous Ketamine on Non Suicidal Self Injuries.NCT04242914Status not reportedPhase 12019-02-25Ketamine
The Effect of Ketamine on Mechanises Underlying Suicidal Ideation and Drug-resistant Major DepressionNCT02037503Status not reportedPhase 32014-01-01Ketamine

About this data

Compound tags come from automated matching of the registry search term and have not been checked record by record. Counts are of registered studies, not of people, results or approvals. A registry listing is not evidence of safety, benefit or results.

Substance hubs for these compounds

Psilocybin | Ketamine

All trial hubs | Learn | Disclaimer